ArticleArchives of toxicology2022

Inhibitors of class I HDACs and of FLT3 combine synergistically against leukemia cells with mutant FLT3.

Vanessa Wachholz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.